Rigel Pharmaceuticals





Ebit Cambiamento Data
Agenus USD -13.31M 19.08M 2025-03
Amgen USD 3.96B 464M 2025-12
Anika Therapeutics USD -4.28M 3.58M 2025-03
Arrowhead Research USD 40.81M 17.01M 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
BioMarin Pharmaceutical USD -31.69M 308.58M 2025-09
Bristol-Myers Squibb USD 3.47B 567M 2025-12
Celldex Therapeutics USD -73.62M 9.76M 2025-09
Daiichi Sankyo JPY 89.54B 42.01B 2025-12
Eli Lilly USD 8.99B 1.57B 2025-12
Halozyme Therapeutics USD 217.92M 15.48M 2025-09
Heron Therapeutics USD -4.46M 5.76M 2024-09
Intrexon USD -26.3M 2.91M 2024-06
Ionis Pharmaceuticals USD -160.18M 304.96M 2025-09
Karyopharm Therapeutics USD -26.28M 1.84M 2024-09
Ligand Pharmaceuticals USD 158.89M 115.32M 2025-09
MacroGenics USD 20.16M 55.51M 2025-09
Neurocrine Biosciences USD 239.3M 93.7M 2025-09
Pfizer USD 4.65B 71M 2025-12
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Rigel Pharmaceuticals USD 447K 1.52M 2024-06
Ultragenyx Pharmaceutical USD -170.89M 22.68M 2025-09
Veracyte USD 23.11M 8.8M 2025-09


Rigel Pharmaceuticals - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.